Skip to content

SeniorWISE: Improving Everyday Memory in At-Risk Elderly

Improving Everyday Memory in At-Risk Elderly

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00094731
Enrollment
260
Registered
2004-10-22
Start date
2001-03-31
Completion date
2006-02-28
Last updated
2009-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging

Keywords

Aging, Memory, Mental Recall, Mental Processes

Brief summary

The purpose of this study is to determine whether classes on memory training will help older adults to improve or maintain their daily activities.

Detailed description

Volunteer participants will be randomly assigned to experimental (memory training) and comparison (health promotion) groups. Both groups will learn strategies for successful aging. Participants will be in the study for 27 months and will be interviewed on five occasions for 3 hours per interview. The classroom-based intervention is an 8-session, 1 1/2 hour course designed to teach older adults the use of strategies to improve everyday memory. Strategically-placed booster sessions will be provided to subjects within 3 months following the last class session.

Interventions

Sponsors

National Institute on Aging (NIA)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Reside in Austin, Texas or Travis County * African, Caucasian, or Hispanic heritage * Fluent in reading and speaking English * Mini Mental Exam scores of 23-30 * Pass executive function test * Adequate hearing and vision to enable participation in classroom learning * Free of Alzheimer's disease or other conditions (e.g., certain cancers) likely to result in mortality before study completion

Exclusion criteria

* Under 65 * Score less than 23 on MMSE * Fail the executive function tests * Severe sensory losses, hearing or vision, that would prohibit testing or participation * self-report a diagnosis of Alzheimer's disease or other conditions (e.g., certain cancers) likely to result in mortality before study completion

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026